Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Current Treatment Options in Psychiatry
Erschienen in:

01.06.2019 | Substance Use Disorders (FG Moeller, Section Editor)

Current State of the Problem: Opioid Overdose Rates and Deaths

verfasst von: S. Hughes Melton, MD, MBA, FAAFP, DABAM, Sarah T. Melton, PharmD, BCPP, BCACP, FASCP

Erschienen in: Current Treatment Options in Psychiatry | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Overdose deaths have increased significantly over the last 5 years. This review analyzes the severity and nature of the epidemic, its impact on society, factors driving the increase in mortality, special populations disproportionately affected, and solutions to decrease overdose deaths. A thorough understanding of opioid overdose rates and deaths position the reader to respond most effectively in their sphere of influence.

Recent findings

Final statistics for 2017 show a continued worsening of the epidemic. Recent studies focus on the evolving role of synthetic fentanyl, risk factors for fatal overdose, variation of mortality across demographic and socioeconomic regions, and the effectiveness of harm reduction strategies such as naloxone.

Summary

The national overdose death rate continues to rise unabated with a 9.6% increase during 2017, with an estimated cost over $550 billion in 2019. There are, however, effective strategies to identify and treat individuals at risk for a fatal overdose. The root cause of addiction is the brain’s response to despair, social stressors, and societal structural inequities. It is unlikely we will see a significant decrease in addiction and its consequences until these root causes are addressed. Additional research is needed on the role of social determinants in addiction, strategies to treat incarcerated individuals, the role of suicidal ideation in fatal overdose, and risk factors, and frequency of non-fatal overdose.
Literatur
1.
Hasegawa K, Brown DF, Tsugawa Y, Camargo CA. Epidemiology of emergency department visits for opioid overdose: a population-based study. Mayo Clin Proc. 2014;89(4):462–71.CrossRefPubMed
2.
Oquendo MA, Volkow ND. Suicide: a silent contributor to opioid-overdose deaths. N Engl J Med. 2018;378(17):1567–9.CrossRefPubMed
3.
Brady JE, Giglio R, Keyes KM, DiMaggio C, Li G. Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis. Inj Epidemiol. 2017;4(1):24.CrossRefPubMedPubMedCentral
4.
5.
6.
7.
•• Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths - United States, 2013-2017.This reference evaluates the worsening of the opioid overdose epidemic wth a focus on the continuing increaes in deaths involving synthetic opioids such as fentanyl. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–27.CrossRefPubMedPubMedCentral
8.
9.
Darke S, Mattick RP, Degenhardt L. The ratio of non-fatal to fatal heroin overdose. Addiction. 2003;98(8):1169–71.CrossRefPubMed
10.
Murphy SL, Xu J, Kochanek KD. Arias E. mortality in the United States. NCHS Data Brief. 2017;2018(328):1–8.
11.
12.
Florence CS, Zhou C, Luo F, Xu L. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care. 2016;54(10):901–6.CrossRefPubMedPubMedCentral
13.
• Dowell D, Noonan RK, Houry D. Underlying factors in drug overdose deaths. JAMA. 2017;318(23):2295–6. This reference evaluates multiple underlying factors associated with overdose deaths with a focus on illicit fentany. Multifaceted actions that must be taken to address the epidemic are described.CrossRefPubMedPubMedCentral
14.
•• Frank RG, Pollack HA. Addressing the Fentanyl Threat to Public Health. N Engl J Med. 2017;376(7):605–7. This reference provides insight why fentanyl poses an ever increasing public health threat. The authors address multiple hard-reduction technologies that should be implemented to decrease overdoses from this potent, synthetic opioid.CrossRefPubMed
15.
16.
Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–9.CrossRefPubMedPubMedCentral
17.
Cerdá M, Tracy M, Galea S. A prospective population based study of changes in alcohol use and binge drinking after a mass traumatic event. Drug Alcohol Depend. 2011;115(1-2):1–8.
18.
• Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: No easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182–6. This reference addresses the role economic and social factors have in opioid overdose. Clear descriptions are provided of the etiology of the role of opioids used as a refuge from physical and psychological trauma, concentrated disadvantage, isolation, and hopelessness.CrossRefPubMedPubMedCentral
19.
Pear VA, Ponicki WR, Gaidus A, Keyes KM, Martins SS, Fink DS, et al. Urban-rural variation in the socioeconomic determinants of opioid overdose. Drug Alcohol Depend. 2018;195:66–73.CrossRefPubMed
20.
Olfson M, Wall M, Wang S, Crystal S, Blanco C. Risks of fatal opioid overdose during the first year following nonfatal overdose. Drug Alcohol Depend. 2018;190:112–9.CrossRefPubMed
21.
Whiteside LK, Goldstick J, Dora-Laskey A, Thomas L, Walton M, Cunningham R, et al. Patient preference for pain medication in the emergency department is associated with non-fatal overdose history. West J Emerg Med. 2018;19(4):722–30.CrossRefPubMedPubMedCentral
22.
Gaither JR, Shabanova V, Leventhal JM. US national trends in pediatric deaths from prescription and illicit opioids, 1999-2016. JAMA Netw Open. 2018;1(8):e186558.CrossRefPubMedPubMedCentral
23.
Finkelstein Y, Macdonald EM, Gonzalez A, Sivilotti MLA, Mamdani MM, Juurlink DN, et al. Overdose risk in young children of women prescribed opioids. Pediatrics. 2017;139(3):e20162887.CrossRefPubMed
24.
VanHouten JP, Rudd RA, Ballesteros MF, Mack KA. Drug overdose deaths among women aged 30-64 years - United States, 1999-2017. MMWR Morb Mortal Wkly Rep. 2019;68(1):1–5.CrossRefPubMedPubMedCentral
25.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.CrossRefPubMed
26.
27.
Brinkley-Rubinstein L, Cloud DH, Davis C, Zaller N, Delany-Brumsey A, Pope L, et al. Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings. Int J Prison Health. 2017;13(1):25–31.CrossRefPubMed
28.
Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183–90.CrossRefPubMedPubMedCentral
29.
30.
Ranapurwala SI, Shanahan ME, Alexandridis AA, Proescholdbell SK, Naumann RB, Edwards D, et al. Opioid overdose mortality among former North Carolina inmates: 2000-2015. Am J Public Health. 2018;108(9):1207–13.CrossRefPubMedPubMedCentral
31.
Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BDL, Alexander-Scott N, Boss R, et al. Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiat. 2018;75(4):405–7.CrossRef
32.
33.
Fink DS, Schleimer JP, Sarvet A, Grover KK, Delcher C, Castillo-Carniglia A, et al. Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: a systematic review. Ann Intern Med. 2018;168(11):783–90.CrossRefPubMedPubMedCentral
34.••
35.
36.
37.
Jones JD, Campbell A, Metz VE, Comer SD. No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone. Addict Behav. 2017;71:104–6.CrossRefPubMedPubMedCentral
38.
McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111(7):1177–87.CrossRefPubMedPubMedCentral
Metadaten
Titel
Current State of the Problem: Opioid Overdose Rates and Deaths
verfasst von
S. Hughes Melton, MD, MBA, FAAFP, DABAM
Sarah T. Melton, PharmD, BCPP, BCACP, FASCP
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Current Treatment Options in Psychiatry / Ausgabe 2/2019
Elektronische ISSN: 2196-3061
DOI
https://doi.org/10.1007/s40501-019-00174-y

Weitere Artikel der Ausgabe 2/2019

Augmenting the Treatment of PTSD with Ketamine—a Review

  • PTSD (S Creech and L Sippel, Section Editors)

New-generation Antipsychotics and Cardiovascular Risk

  • Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor)

Augmenting Treatment for Posttraumatic Stress Disorder and Co-Occurring Conditions with Oxytocin

  • PTSD (S Creech and L Sippel, Section Editors)

Dealing with Complexity and Comorbidity: Opportunity for Transdiagnostic Treatment for PTSD

  • PTSD (S Creech and L Sippel, Section Editors)

Adjusting the Timeframe of Evidence-Based Therapies for PTSD-Massed Treatments

  • PTSD (S Creech and L Sippel, Section Editors)

Brief Novel Therapies for PTSD: Written Exposure Therapy

  • PTSD (S Creech and L Sippel, Section Editors)

Neu im Fachgebiet Psychiatrie

Medikamente verändern wohl Nährstoffzusammensetzung der Muttermilch

Einige Medikamente wie selektive Serotonin-Wiederaufnahmehemmer können offenbar die Makronährstoffzusammensetzung der Muttermilch verändern. Das birgt möglicherweise gesundheitliche Risiken für manche gestillte Kinder.

Psychologische Interventionen können Depressionen oft verhindern

Gespräche, Telefonate, internetbasierte Verfahren: Mit solchen Methoden lässt sich der Beginn einer Depression bei gefährdeten Personen oft vermeiden. Sie funktionieren vor allem dann, wenn die Betroffenen deutliche Symptome aufweisen und noch keine Psychotherapie hatten.

Die beste Medizin gegen Altersdepression: Laufen, Lernen, Lachen, Lieben

Depressionen im Alter haben vielfältige Ursachen und verlaufen anders als bei jungen Menschen. Ohne einen multimodalen Ansatz kommt man oft nicht weit: Neben Medikamenten und Psychotherapien ist die physische, kognitive und soziale Aktivierung entscheidend.

Wir sozio-emotionalen Blobs

Entscheidungen sollten rational erfolgen – in der Politik wie im Leben. So wünschen wir uns das. Letztlich werden sie aber von Emotionen bestimmt. Wer das nicht versteht und anerkennt, wird kaum Wege aus Krisen finden. Die Neurowissenschaftlerin Maren Urner fordert daher eine „Reifeprüfung“ zur Krisenbewältigung.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise